Christopher M. Smith - Aug 2, 2021 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc (OCDX)

Role
Chairman and CEO, Director
Signature
/s/ Michael A. Schlesinger, Attorney-in-Fact
Stock symbol
OCDX
Transactions as of
Aug 2, 2021
Transactions value $
-$5,890,487
Form type
4
Date filed
8/4/2021, 06:29 PM
Previous filing
Jun 25, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCDX Ordinary Shares, $0.00001 par value Sale -$2.28M -103K -16.19% $22.10 534K Aug 2, 2021 Direct F1, F2, F3
transaction OCDX Ordinary Shares, $0.00001 par value Sale -$2.26M -105K -19.66% $21.55 429K Aug 3, 2021 Direct F1, F2, F4
transaction OCDX Ordinary Shares, $0.00001 par value Sale -$1.35M -61.8K -14.4% $21.79 367K Aug 4, 2021 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
F3 Represents the weighted average sales price for the price increments from $21.90 to $22.51.
F4 Represents the weighted average sales price for the price increments from $21.00 to $21.90.
F5 Represents the weighted average sales price for the price increments from $21.57 to $21.92.